| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9570 |
| Human Intestinal Absorption | HIA+ | 0.9203 |
| Caco-2 Permeability | Caco2+ | 0.6503 |
| P-glycoprotein Substrate | Non-substrate | 0.7244 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7841 |
| Non-inhibitor | 0.8937 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8379 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8961 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8538 |
| CYP450 2D6 Substrate | Non-substrate | 0.9158 |
| CYP450 3A4 Substrate | Non-substrate | 0.7578 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5917 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7383 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8947 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5167 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7200 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6008 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9412 |
| Non-inhibitor | 0.9778 |
| AMES Toxicity | Non AMES toxic | 0.9147 |
| Carcinogens | Non-carcinogens | 0.6926 |
| Fish Toxicity | High FHMT | 0.9957 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9981 |
| Honey Bee Toxicity | High HBT | 0.6745 |
| Biodegradation | Ready biodegradable | 0.7563 |
| Acute Oral Toxicity | III | 0.8309 |
| Carcinogenicity (Three-class) | Non-required | 0.7250 |